Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
Actions
Etats-Unis
NASDAQ
BioMarin Pharmaceutical Inc (BMRN)
BioMarin Pharmaceutical Inc (BMRN) Actualités

BioMarin Pharmaceutical Inc (BMRN)

58,99

1,17

(2,02%)

Fermé 03 Juillet 10:00PM

58,71

-0,28

(-0,47%)

Après les heures de négociation: 1:59AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results at ENDO 2026

BioMarin Announces New Three-Year VOXZOGO® (vosoritide) Data in Hypochondroplasia and BMN 333 Early Results...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia

BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with...

BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency

BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency PR...

Form 4 - Statement of changes in beneficial ownership of securities

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

BioMarin Pharmaceutical

UBS CMCI Future Commodit...

Domika Kritis R

Mgc Pharmaceuticals

Rapid Micro Biosystems

Goldsky Resources (QX)

Navis Resources

DealNet Capital

GLOBAL X DISTRUPTIVE MAT...

Eqty Lkd Nts 31/10/30

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.